J Raper1, J C De Biasio2, K L Murphy3, M C Alvarado4, M G Baxter2. 1. Division of Developmental and Cognitive Neuroscience, Yerkes National Primate Research Center, Atlanta, GA, USA. Electronic address: jraper@emory.edu. 2. Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Anesthesiology, Perioperative and Pain Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 3. Comparative Biology Centre, Newcastle University, Newcastle, UK. 4. Division of Developmental and Cognitive Neuroscience, Yerkes National Primate Research Center, Atlanta, GA, USA.
Abstract
BACKGROUND: Socio-emotional development is the expression and management of emotions, which in non-human primates can be examined using responses toward increasing levels of threat. Damage to the limbic system alters socio-emotional development in primates. Thus, neuronal and glial cell loss caused by exposure to general anaesthesia early in infancy might also impact socio-emotional development. We recently reported that repeated sevoflurane exposure in the first month of life alters emotional behaviours at 6 months of age and impairs visual recognition memory after the first year of life in rhesus monkeys. The present study evaluated socio-emotional behaviour at 1 and 2 yr of age in those same monkeys to determine the persistence of altered emotional behaviour. METHODS: Rhesus monkeys of both sexes were exposed to sevoflurane anaesthesia three times for 4 h each time in the first 6 weeks of life. At 1 and 2 yr of age, they were tested on the human intruder task, a well-established mild acute social stressor. RESULTS: Monkeys exposed to sevoflurane as infants exhibited normal fear and hostile responses, but exaggerated self-directed (displacement) behaviours, a general indicator of stress and anxiety in non-human primates. CONCLUSIONS: Early repeated sevoflurane exposure in infant non-human primates results in an anxious phenotype that was first detected at 6 months, and persists for at least 2 yr of age. This is the first demonstration of such a prolonged impact of early anaesthesia exposure on emotional reactivity.
BACKGROUND: Socio-emotional development is the expression and management of emotions, which in non-human primates can be examined using responses toward increasing levels of threat. Damage to the limbic system alters socio-emotional development in primates. Thus, neuronal and glial cell loss caused by exposure to general anaesthesia early in infancy might also impact socio-emotional development. We recently reported that repeated sevoflurane exposure in the first month of life alters emotional behaviours at 6 months of age and impairs visual recognition memory after the first year of life in rhesus monkeys. The present study evaluated socio-emotional behaviour at 1 and 2 yr of age in those same monkeys to determine the persistence of altered emotional behaviour. METHODS:Rhesus monkeys of both sexes were exposed to sevoflurane anaesthesia three times for 4 h each time in the first 6 weeks of life. At 1 and 2 yr of age, they were tested on the human intruder task, a well-established mild acute social stressor. RESULTS: Monkeys exposed to sevoflurane as infants exhibited normal fear and hostile responses, but exaggerated self-directed (displacement) behaviours, a general indicator of stress and anxiety in non-human primates. CONCLUSIONS: Early repeated sevoflurane exposure in infant non-human primates results in an anxious phenotype that was first detected at 6 months, and persists for at least 2 yr of age. This is the first demonstration of such a prolonged impact of early anaesthesia exposure on emotional reactivity.
Authors: Brittany R Howell; Jodi Godfrey; David A Gutman; Vasiliki Michopoulos; Xiaodong Zhang; Govind Nair; Xiaoping Hu; Mark E Wilson; Mar M Sanchez Journal: Cereb Cortex Date: 2013-08-01 Impact factor: 5.357
Authors: Katie J Schenning; Kevin K Noguchi; Lauren Drew Martin; Francesca M Manzella; Omar H Cabrera; Gregory A Dissen; Ansgar M Brambrink Journal: Neurotoxicol Teratol Date: 2016-11-19 Impact factor: 3.763
Authors: Randall P Flick; Slavica K Katusic; Robert C Colligan; Robert T Wilder; Robert G Voigt; Michael D Olson; Juraj Sprung; Amy L Weaver; Darrell R Schroeder; David O Warner Journal: Pediatrics Date: 2011-10-03 Impact factor: 7.124
Authors: Ansgar M Brambrink; Alex S Evers; Michael S Avidan; Nuri B Farber; Derek J Smith; Xuezhao Zhang; Gregory A Dissen; Catherine E Creeley; John W Olney Journal: Anesthesiology Date: 2010-04 Impact factor: 7.892
Authors: Danqing Hu; Randall P Flick; Michael J Zaccariello; Robert C Colligan; Slavica K Katusic; Darrell R Schroeder; Andrew C Hanson; Shonie L Buenvenida; Stephen J Gleich; Robert T Wilder; Juraj Sprung; David O Warner Journal: Anesthesiology Date: 2017-08 Impact factor: 7.892
Authors: Gregory A Chinn; Matthew L Pearn; Laszlo Vutskits; Cyrus D Mintz; Andreas W Loepke; Jennifer J Lee; Jerri Chen; Zeljko J Bosnjak; Ansgar M Brambrink; Vesna Jevtovic-Todorovic; Lena S Sun; Jeffrey W Sall Journal: Br J Anaesth Date: 2020-03-04 Impact factor: 9.166
Authors: Daojie Xu; Bin Wang; Bo Xu; Chen Yin; Li Ning; Xiaoquan Li; Jiulin Du; Yingwei Wang Journal: Mol Neurobiol Date: 2021-10-09 Impact factor: 5.590
Authors: Viola Neudecker; Jose F Perez-Zoghbi; Lauren D Martin; Gregory A Dissen; Marjorie R Grafe; Ansgar M Brambrink Journal: Br J Anaesth Date: 2021-07-13 Impact factor: 11.719